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Brucellosis is an infectious disease elicited by bacteria of the genus Brucella. Platelets 
have been extensively described as mediators of hemostasis and responsible for 
maintaining vascular integrity. Nevertheless, they have been recently involved in the 
modulation of innate and adaptive immune responses. Although many interactions have 
been described between Brucella abortus and monocytes/macrophages, the role of 
platelets during monocyte/macrophage infection by these bacteria remained unknown. 
The aim of this study was to investigate the role of platelets in the immune response 
against B. abortus. We first focused on the possible interactions between B. abortus and 
platelets. Bacteria were able to directly interact with platelets. Moreover, this interaction 
triggered platelet activation, measured as fibrinogen binding and P-selectin expression. 
We further investigated whether platelets were involved in Brucella-mediated monocyte/
macrophage early infection. The presence of platelets promoted the invasion of mono-
cytes/macrophages by B. abortus. Moreover, platelets established complexes with 
infected monocytes/macrophages as a result of a carrier function elicited by platelets. 
We also evaluated the ability of platelets to modulate functional aspects of monocytes 
in the context of the infection. The presence of platelets during monocyte infection 
enhanced IL-1β, TNF-α, IL-8, and MCP-1 secretion while it inhibited the secretion of 
IL-10. At the same time, platelets increased the expression of CD54 (ICAM-1) and CD40. 
Furthermore, we showed that soluble factors released by B. abortus-activated platelets, 
such as soluble CD40L, platelet factor 4, platelet-activating factor, and thromboxane A2, 
were involved in CD54 induction. Overall, our results indicate that platelets can directly 
sense and react to B. abortus presence and modulate B. abortus-mediated infection 
of monocytes/macrophages increasing their pro-inflammatory capacity, which could 
promote the resolution of the infection.
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inTrODUcTiOn
Brucella abortus is one of the etiological agents of brucellosis, a worldwide zoonotic disease. Human 
brucellosis has a wide clinical spectrum and is characterized by its tendency to chronicity, associ-
ated with successive relapses from acute episodes or focal manifestations (1–3). Brucellosis patients 
may present diverse hematological alterations, from anemia and leukopenia up to severe hemostatic 
2
Trotta et al. Platelets Promote B. abortus Monocyte Invasion
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1000
disorders. Moreover, a reduced platelet count in the bloodstream, 
i.e., thrombocytopenia, is frequently observed and might be 
severe (4–6). Although thrombocytopenia is associated with a 
higher rate of relapses (5, 7), the etiology of this disorder has not 
been elucidated yet. Even more, the role of platelets in the context 
of Brucella infection remains completely unknown.
Bacteria from the genus Brucella are Gram-negative micro-
organisms able to survive and reproduce inside phagocytic cells 
as facultative intracellular pathogens. Once inside their host, 
these bacteria have an extracellular dissemination phase before 
reaching the macrophage, their preferential intracellular niche. 
Platelets, along with neutrophils and monocytes, are one of the 
first cells to encounter bacteria during this extracellular phase (2, 
3). Then, bacteria are phagocyted by neutrophils and monocytes, 
and transported by the bloodstream to the liver’s sinusoids, 
spleen, bone marrow, and lymph nodes, where they are able to 
multiply and survive inside macrophages.
Brucella abortus infection activates both innate and adaptive 
immune responses and generates a pro-inflammatory environ-
ment that favors the differentiation of CD4+ T cells toward a Th1 
phenotype (8–11). However, B. abortus is able to persist inside 
the macrophages evading the host immune response. This ability 
determines the disease progression, which includes its tendency 
to recidivism and evolution into chronic forms (1–3).
Platelets have been thoroughly described as hemostatic medi-
ators and responsible for maintaining vascular integrity (12). 
Nevertheless, recent studies have demonstrated that platelets also 
have an important role in the modulation of innate and adaptive 
immune responses (12–15). As well as the receptors for thrombotic 
stimuli as collagen (GPVI), adenosine-di-phosphate (P2Y1/12), 
and thrombin (PAR1/4), platelets have a wide spectrum of recep-
tors for pathogenic and immunological molecules, similar to 
professional phagocytes (16). Toll-like receptors (TLRs), receptors 
for complement and for the Fc portion of the IgG (FcγRII), are 
included within this group of receptors (17, 18). Through these 
receptors, platelets can become activated in response to different 
microorganisms and secrete a vast amount of products contained 
in their granules (19–21). Among these products are soluble 
CD40L (sCD40L), platelet-activating factor (PAF), thrombox-
ane A2 (TXA2), and several pro-inflammatory cytokines and 
immunomodulatory chemokines such as platelet factor 4 (PF4), 
RANTES, and CXCL7 (22, 23). Moreover, it has been demon-
strated that platelets are able to produce and secrete antimicrobial 
molecules, including defensins and thrombocidins (24–27).
In the past few years, there have been significant advances in 
the study of the interactions of platelets with several infectious 
agents (12–14). Beyond their ability to respond to different patho-
gens and bactericide activity, platelets can also lead the innate 
and adaptive immune responses through their interaction with 
several leukocyte populations, particularly with neutrophils and 
monocytes (28–30). Upon activation, platelets expose P-selectin 
on their surface, which facilitates the interaction with neutrophils 
and monocytes, and allows the formation of platelet–leukocyte 
complexes or aggregates (31). In the case of neutrophils, it has 
been described that this particular interaction leads to neutro-
phil extracellular traps (NETs) formation, which contributes 
to the restraint of bacterial infection (24, 32). Regarding 
platelet–monocyte complexes, it has been reported that platelets 
can modulate the secretion of several monocyte cytokines, such 
as IL-10 and TNF-α (13, 33) and the surface expression of co-
stimulatory molecules in response to bacterial stimulation (13). 
Overall, these responses might facilitate the control of the infec-
tion, but can also contribute to the pathogenesis of the infectious 
disease (12, 14). Thus, platelets can play either a beneficial or a 
detrimental role during infection elicited by different pathogens.
Important progress has been made in the study of platelets 
interactions with infectious agents and the modulation of 
immune responses mediated by platelets. Despite this, whether 
platelets interact with bacteria of genus Brucella and/or are able 
to modulate any aspect of the Brucella-elicited immune response 
still remains unknown. Therefore, the aim of this work was to 
elucidate the role of platelets in the immune response against 
B. abortus. In this study, we first focused on the possible interac-
tion between B. abortus and platelets. Once this phenomenon was 
corroborated, we investigated the role of platelets in the develop-
ment of monocyte/macrophage early infection by B. abortus. 
Here, we present the results of this study.
MaTerials anD MeThODs
ethics statement
Human platelets and monocytes were isolated exclusively from 
healthy adult blood donors in agreement with the guidelines of 
the Ethical Committee of the IMEX Institute (protocol number: 
20160518-M). All adult blood donors provided their informed 
consent prior to the study in accordance with the Declaration of 
Helsinki (2013) of the World Medical Association.
Bacteria
Brucella abortus S2308 and green fluorescence protein (GFP)- 
S2308 (34) were cultured in tryptose-soy agar supplemented with 
yeast extract (Merck). The number of bacteria on stationary-
phase cultures was determined by comparing the OD at 600 nm 
to a standard curve. All live Brucella manipulations were per-
formed in biosafety level 3 facilities, located at the Instituto de 
Investigaciones Biomédicas en Retrovirus y SIDA (Buenos Aires, 
Argentina).
regents
Recombinant PF4 was purchased from PeproTech. Both recom-
binant CD40L and the anti-CD40L neutralizing antibody were 
purchased from BioLegend. Acetylsalicylic Acid (Aspirin) was 
purchased from Sigma-Aldrich. Anti-PF4 neutralizing antibody 
was purchased from Abcam.
cells and Media
All experiments were performed at 37°C in 5% CO2 atmosphere 
and standard medium composed of RPMI-1640 supplemented 
with 25 mM Hepes, 2 mM l-glutamine, 10% heat-inactivated fetal 
bovine serum (Gibco), 100 U of penicillin/ml, and 100 µg of strep-
tomycin/ml. THP-1 cells were obtained from the American Type 
Culture Collection (Manassas, VA, USA) and cultured as previ-
ously described (35). To induce maturation, cells were cultured 
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in 0.05 µM 1,25-dihydroxyvitamin D3 (EMD Millipore) for 72 h. 
Peripheral blood mononuclear cells (PBMCs) were obtained by 
Ficoll-Hypaque (GE Healthcare) gradient centrifugation from 
human blood collected from healthy adult individuals. Monocytes 
were then purified from PBMCs by Percoll (GE Healthcare) 
gradient and resuspended in standard medium. Purity of the 
isolated CD14+ monocytes was more than 80% as determined by 
flow cytometry. Viability of cells was more than 95% in all the 
experiments as measured by trypan blue exclusion test.
Platelets
Washed platelets (WPs) were obtained from human whole blood 
from healthy adult donors. Blood samples were directly collected 
into plastic tubes containing 3.8% sodium citrate (10:1) (Merck). 
Platelet-rich plasma (PRP) was obtained by blood sample cen-
trifugation. To avoid leukocyte contamination, only the top 75% 
of the PRP was collected. The PRP was centrifuged in presence of 
75 nM prostaglandin I2 (PGI2) (Cayman Chemical), and platelets 
were then washed with RPMI-1640 medium. Finally, WPs were 
resuspended in RPMI-1640 medium.
Fibrinogen-Binding assay
Platelets were incubated with B. abortus (PLT:Ba ratio of 1:10) or 
0.05 U of thrombin/ml for 10 min at room temperature in pres-
ence of Alexa 488-labeled fibrinogen. Then, platelets were fixed 
in a 4% paraformaldehyde solution, and fibrinogen binding was 
evaluated by flow cytometry.
P-selectin expression assay
Platelets were incubated with B. abortus (PLT:Ba ratio of 1:10) or 
0.05 U of thrombin/ml for 10 min at room temperature. Platelets 
were then stained with FITC-labeled anti-human P-selectin anti-
body (BD Biosciences) or its isotype control and the expression 
of surface P-selectin was evaluated by flow cytometry.
In Vitro infection
THP-1 cells at a concentration of 0.5 × 106/ml were infected in 
round-bottom polypropylene tubes (Falcon) with a multiplicity 
of infection (MOI) of 100 of B. abortus S2308 or GFP-S2308, 
in presence or absence of platelets (THP-1:PLT ratio 1:100). 
All infections were performed for 2 or 4 h in standard medium 
containing no antibiotics. In all cases, cells were then extensively 
washed to remove uninternalized bacteria, and infected cells 
were maintained in culture in medium supplemented with 
100 µg of gentamicin/ml and 50 µg of streptomycin/ml. At dif-
ferent times post-infection, supernatants were collected, filtered, 
and stored at −70°C for later determination by Enzyme Linked 
ImmunoSorbent Assay (ELISA). In another set of experiments, 
the cells were equally infected with B. abortus in presence or 
absence of platelets, and the expression of surface markers was 
evaluated by flow cytometry.
Platelet supernatants for Monocyte 
stimulation
Brucella abortus (1  ×  107/ml) were incubated with platelets 
(PLT:Ba ratio of 1:1) for 4 h. Then, the supernatants were collected, 
sterilized by filtration, ultracentrifuged, and stored at −70°C.
colony-Forming Units (cFU) count
Platelets Infection Assay
Platelets were infected with B. abortus at different concentrations 
for 2 h in standard medium containing no antibiotics. In all cases, 
platelets were then treated with 100 µg of gentamicin/ml and 50 µg 
of streptomycin/ml for 30  min to eliminate all uninternalized 
bacteria. Finally, platelets were lysed with 0.01% v/v Triton X-100 
and the lysate was plated in tryptose-soy agar supplemented with 
yeast extract. The CFU were counted 4 days post-plated.
Monocytes Infection Assay
THP-1 cells were infected with B. abortus (MOI 100) in pres-
ence of platelets at different concentrations (THP-1:PLT ratio of 
1:1, 1:10, and 1:100) for 2 h in standard medium containing no 
antibiotics. In all cases, monocytes were then treated with 100 µg 
of gentamicin/ml and 50  µg of streptomycin/ml for 30  min to 
eliminate all uninternalized bacteria and incubated for differ-
ent times as specified in each figure. Finally, monocytes were 
lysed with 0.01% v/v Triton X-100, and the lysate was plated in 




Whole blood of healthy donors was stimulated with B. abortus 
(2 × 105 bacteria/ml) for 30 min. Then, monocytes were stained 
with a PerCP-labeled anti-CD14 (BioLegend) and platelets with 
a PE-labeled anti-CD61 antibody (BD Biosciences). Finally, 
the samples were fixed, and red blood cells were lysed with 
BD FACS® Lysing Solution (BD Biosciences) and analyzed on 
a FACSCalibur® flow cytometer (BD Biosciences). Cells from 
whole blood were plotted on a CD14 vs. SSC dot plot. Then, the 
CD14+ cells were plotted on a CD14 vs. CD61 dot plot. Finally, 
the presence of platelet–monocyte complexes (CD14+CD61+) 
was determined. Data were processed using CellQuest software 
(BD Bioscience) or FlowJo® 7.6 software (LLC).
enzyme linked immunosorbent assay
Human TNF-α (BD Bioscience), IL-1β (BioLegend), IL-10 
(BioLegend), IL-8 (BioLegend), and MCP-1 (BD Bioscience) 
concentration was measured in culture supernatants of mono-
cytes, B. abortus, and/or platelets by sandwich ELISA, using 
paired cytokine-specific Abs according to the manufacturer’s 
instructions.
Flow cytometry
THP-1 cells (0.5 × 106/ml) were infected with a multiplicity of 
infection of B. abortus S2308 (MOI 100) in presence or absence 
of platelets (THP-1:PLT ratio of 1:100) for 4 h. Cells were then 
washed to remove uninternalized bacteria and cells were stained 
with PE-labeled anti-human CD54 (clone HA58; BioLegend), 
anti-human CD40 (clone 5C3; BioLegend) or their isotype-
matched control Abs. After labeling, cells were analyzed on a 
FACSCalibur® flow cytometer (BD Biosciences), and data were 
processed using CellQuest software (BD Bioscience) or FlowJo® 
7.6 software (LLC).
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confocal Microscopy
Platelet–B. abortus Interaction
Platelets (5  ×  106 platelet/well) were incubated with GFP-B. 
abortus (PLT:Ba ratio of 1:1, 1:10, and 1:30) in RPMI medium for 
2 h in chamber-slides pre-treated with 7.5 ng of Poly l-lysine/ml. 
Then, cells were fixed with 2% paraformaldehyde and stained with 
an anti-CD61 Ab (VI-PL2; BD Bioscience) followed by an Alexa 
546-labeled secondary Ab (Molecular Probes Life Technologies).
Monocyte–B. abortus–Platelet Interaction
THP-1 cells (2  ×  105  cells/well) were incubated in chamber-
slides with 10  ng of PMA/ml for 24  h to promote adherence. 
Then, cells were treated as indicated in each figure, fixed with 
2% paraformaldehyde and permeabilized with 0.1% saponin. 
The samples were then incubated with an anti-HLA-ABC class 
I mAb (W6/32) followed by Alexa 633-labeled secondary Ab 
(Molecular Probes Life Technologies) and an anti-CD61 Ab (VI-
PL2; BD Bioscience) followed by an Alexa 546-labeled secondary 
Ab (Molecular Probes Life Technologies).
In all cases, slides were mounted with PolyMount (Polysciences) 
and analyzed using a FV-1000 confocal microscope with an oil-
immersion Plan Apochromatic 60× NA1.42 objective (Olympus). 
The obtained images were processed with FIJI software (open 
source).
statistical analysis
Results were analyzed with one or two-way ANOVA followed by 
post hoc Tukey test using the GraphPad Prism software.
resUlTs
B. abortus Directly interacts With Platelets
We first investigated whether a direct interaction between 
B. abortus and platelets occurs. For this, platelets were co-
incubated with GFP-B. abortus at different ratios (Platelet:GFP- 
B. abortus 1:1, 1:10, and 1:30) for 4 h. Then, platelets were stained 
with an anti-CD61 antibody and the platelet–B. abortus interac-
tion was quantified by confocal microscopy (Figures 1A,B) and 
flow cytometry (Figure 1C and gating strategy shown in Figure S1 
in Supplementary Material). B. abortus was able to directly bind to 
platelets and this interaction increased in a dose-dependent man-
ner (Figures 1A–C). Taking into account that several bacteria are 
able to modify platelet function (36), we next evaluated whether 
the physical interaction with B. abortus was able to modulate 
platelet functional responses. For this, platelets were incubated 
with B. abortus and platelet activation was then evaluated by flow 
cytometry within the platelet gate determined in the FSC vs. SSC 
dot plot as showed in Figure S1A in Supplementary Material. 
B. abortus was able to significantly increase both fibrinogen bind-
ing and P-selectin expression, though to a lesser extent than the 
platelet activator thrombin (Figures 1D,E). Next, we wondered 
whether B. abortus was able to invade platelets. For this, platelets 
were incubated with different multiplicities of infection (MOI) of 
B. abortus for 2 h. Afterward, extracellular bacteria were killed by 
adding antibiotics, platelets were lysed, and the number of viable 
intracellular bacteria was determined by plating the lysates on 
tryptose-soy agar. As shown in Figure  1F, B. abortus was able 
to invade platelets in a dose-dependent manner. Overall, these 
results demonstrate that B. abortus is able to directly interact with 
and invade platelets, triggering their activation.
Platelets Promote Monocyte/Macrophage 
invasion by B. abortus
Once the interaction between platelets and bacteria was dem-
onstrated, and taking into consideration that monocytes/mac-
rophages are the main niche for B. abortus replication, we further 
investigated the capacity of platelets to modulate the monocytes/
macrophages infection mediated by B. abortus. For this, THP-1 
cells were infected with GFP-B. abortus for 4 h, in presence or 
absence of platelets and THP-1 infection was assessed by confocal 
microscopy. As shown in Figures 2A–C, the presence of platelets 
significantly increased the percentage of B. abortus-infected 
THP-1 cells (GFP+). This phenomenon was reproduced using 
human monocytes purified from peripheral blood (Figure 2D). 
Altogether, these results indicate that the presence of platelets 
promote the invasion of monocytes/macrophages by B. abortus 
at early times during infection.
Platelets establish complexes With  
B. abortus-infected Monocytes
Having demonstrated the interaction between platelets and 
bacteria and the promotion of monocyte invasion, we wondered 
how the interactions between these three cell populations were. 
For this, THP-1 cells were incubated with platelets in a THP-
1:Platelet ratio of 1:100, in presence or absence of GFP-B. abortus 
(MOI 100 respect to THP-1) for 4  h. Then, monocytes were 
stained with anti-MHC-I (blue) and platelets with anti-CD61 
(red) antibodies. Finally, samples were assessed by confocal 
microscopy. Monocytes established complexes with platelets in 
presence of B. abortus (Figure 3A). Interestingly, platelets were 
associated with monocytes that were infected with B. abortus 
(Ba-positive monocytes) (Figures 3B,D). Next, the formation of 
platelet–monocyte complexes mediated by B. abortus was quanti-
fied. For this, the number of monocytes per field was quantified 
and we analyzed which of them were infected (Ba-positive), not 
infected (Ba-negative), associated with platelets (PLT-positive) or 
not associated with platelets (PLT-negative). The percentage of 
double-negative monocytes (not infected and not associated with 
platelets), double-positive (infected and associated with platelets), 
and single-positive (not infected but associated with platelets, or 
infected but not associated with platelets) was represented. Only 
B. abortus-infected monocytes were able to establish complexes 
with platelets (Figure  3C). Moreover, as shown in Figure  3D 
and Video S1 in Supplementary Material, platelets were disposed 
around the infected monocytes so as to surround them com-
pletely. Next, we wondered whether these platelet–monocyte 
complexes could be established in whole blood. For this, whole 
blood of healthy donors was incubated with B. abortus and then 
stained with anti-CD14 and anti-CD61 antibodies. Afterward, the 
presence of platelet–monocyte complexes (CD14+CD61+) within 
the CD14+ gate was assessed by flow cytometry (Figures 4A,B). 
As shown in Figures  4A–C, B. abortus was able to increase 
FigUre 1 | There is a direct interaction between platelets and Brucella abortus. (a) Confocal micrographs of platelets incubated with green fluorescence protein 
(GFP)-B. abortus at different ratios (Platelet:GFP-B. abortus 1:1, 1:10, and 1:30) for 4 h. Platelet population was stained with an anti-human CD61 primary Ab and 
Alexa 546-labeled secondary Ab (red). (B) Quantification of platelet–B. abortus interaction by confocal microscopy. The number of platelets counted per 
experimental group was 200. (c) Quantification of platelet–B. abortus interaction by flow cytometry. Data are expressed as the percentage of platelets associated 
with B. abortus (GFP-positive platelets) ± SEM of three independent experiments. Platelets were also incubated with B. abortus for 30 min and their activation 
status was measured as Fibrinogen binding (D) and P-selectin expression (e). The platelet activator thrombin was used as control. Bars represent the arithmetic 
means ± SEM of three experiments or the percentage of platelets that express P-selectin. MFI, mean fluorescence intensity. (F) Quantification of platelet invasion  
by B. abortus. Data are expressed as colony-forming units (CFU) per ml. ***P < 0.001 vs. untreated; ###P < 0.001.
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not only the percentage of monocytes bound to platelets (% of 
CD14+CD61+ cells) but also the quantity of adhered platelets 
per monocyte (CD61 expression on cells corresponding to 
CD14+CD61+ Quadrant) (Figure  4D). Overall, these results 
demonstrate that the presence of B. abortus promotes the estab-
lishment of platelet–monocyte complexes. Interestingly though, 
platelets exclusively surround monocytes infected with B. abortus.
Platelets act as carriers of Bacteria 
Toward Monocytes
The fact that platelets form complexes with B. abortus-infected 
monocytes led us to postulate two possible hypotheses regarding 
the mechanism involved in this phenomenon: either (1) infected 
monocytes increase the expression of some surface molecules or 
receptors, supporting the specific binding of platelets or (2) acti-
vated platelets act as carriers of bacteria, transporting them toward 
the monocytes and, in this way, promoting monocyte infection. 
To evaluate the first hypothesis, THP-1 cells were infected with 
GFP-B. abortus (MOI 100) for 2 h. Then, cells were washed and 
incubated with platelets for additional 2 h. Monocytes incubated 
for 2 h in absence of B. abortus were used as control (data not 
shown). Finally, the samples were stained with anti-MHC-I 
(blue) and anti-CD61 (red) antibodies and assessed by confocal 
microscopy. When monocytes were first infected with B. abortus 
FigUre 2 | Platelets promote monocyte/macrophage invasion by Brucella abortus. (a) Confocal micrographs of THP-1 cells infected with green fluorescence 
protein (GFP)-B. abortus in presence or absence of platelets for 4 h. (B) Confocal micrographs of THP-1 cells infected with GFP-B. abortus in presence of  
platelets for 4 h. Platelets were stained with an anti-human CD61 primary Ab and Alexa-546-labeled secondary Ab (red). (c) Quantification of THP-1 cell invasion by 
B. abortus. (D) Quantification of peripheral blood-isolated human monocyte invasion by B. abortus. Data are expressed as the percentage of monocytes invaded 
(GFP-positive monocytes) ± SEM of three independent experiments. The number of cells counted per experimental group was 200. *P < 0.05; **P < 0.01 vs. 
monocytes without platelets. THP-1:PTL:Ba 1:100:100.
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and incubated with platelets afterward, the obtained percentage 
of infection was similar to the control condition of B. abortus-
infected monocytes in absence of platelets (Figures  5A,C). 
Moreover, it was observed that infected monocytes were not 
surrounded by platelets as in the monocyte–B. abortus–platelet 
co-incubation treatment (Figure 5A). In this case, although some 
platelets were attached to the surface of infected monocytes, the 
number and disposition of platelets around monocytes was dif-
ferent from the co-incubation experiments (Figure 5A).
To evaluate the second hypothesis, platelets were incubated 
with GFP-B. abortus for 2 h. Next, THP-1 cells were incubated 
with B. abortus-stimulated platelet suspension for additional 
2  h. A suspension of platelets incubated for 2  h in absence of 
B. abortus was used as control (data not shown). Finally, the 
samples were stained as described before and assessed by confo-
cal microscopy. When monocytes were stimulated with the pre-
incubated suspension of platelets and B. abortus, the percentage 
of infection was higher than the experimental condition shown 
in Figure 5A (Figures 5B,C). In addition, using this experimen-
tal approach, B. abortus-infected monocytes associated with 
platelets were observed. Furthermore, platelets completely sur-
rounded the infected monocytes in the same manner as described 
in the monocyte–B. abortus–platelet co-incubation treatment 
(Figure  5B; Video S2 in Supplementary Material). Supporting 
the carrier activity of platelets, it was observed the presence of 
platelets delivering bacteria to monocytes (Figures 5D,E; Video 
FigUre 3 | Platelets surround Brucella abortus-infected monocytes. (a) Confocal micrographs of THP-1 cells infected with green fluorescence protein  
(GFP)-B. abortus in presence or absence of platelets for 4 h. Monocyte population was stained with an anti-human MHC-I primary Ab and Alexa-633-labeled 
secondary Ab (blue). Platelet population was stained with an anti-human CD61 primary Ab and Alexa-546-labeled secondary Ab (red). (B) Confocal panoramic 
micrograph of THP-1 cells infected with GFP-B. abortus in presence of platelets, representative of the micrographs used for the interaction quantification.  
(c) Quantification of the interactions between populations. The monocytes subpopulations were defined as: non-infected and without platelets (double-negatives), 
infected and associated with platelets (double-positives), only infected (GFP-positives), and only associated with platelets (CD61-positives). Data are expressed as 
percentage of monocytes ± SEM of three independent experiments. The number of cells counted per experimental group was 200. (D) Merge Z-stack and 
orthogonal view of THP-1 cells infected with GFP-B. abortus in presence of platelets for 4 h. Blue arrows indicate non-infected THP-1 cells while white arrows 
indicate infected THP-1 cells surrounded by platelets.
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S3 in Supplementary Material). Overall, these results indicate 
that the infection of monocytes does not induce the formation of 
platelet–monocyte complexes. Instead, the interaction between 
platelets and bacteria triggers platelet activation and promote 
platelets to act as carriers of bacteria toward monocytes. As a 
result, B. abortus-infected monocytes remain associated with the 
platelets that transported bacteria toward them.
Platelets Modulate cytokine and 
chemokine secretion in the context of  
B. abortus infection
After studying the interaction among monocytes, B. abortus, 
and platelets, we decided to evaluate the ability of platelets 
to modulate functional aspects of monocytes/macrophages. 
Particularly, we focused on the immunomodulatory cytokine/
chemokine secretion, a key aspect of immunity against bacterial 
infections. For this, THP-1 cells were infected with B. abortus 
in presence or absence of platelets for different time periods. 
Then, supernatants were collected and the secretion of different 
cytokines and chemokines was quantified by ELISA. B. abortus 
infection increased the secretion of IL-1β, TNF-α, IL-10, IL-8, 
and MCP-1. The presence of platelets during monocyte infection 
enhanced the secretion of the pro-inflammatory cytokines IL-1β 
and TNF-α (Figures 6A–D), and the chemokines IL-8 and MCP-1 
at both analyzed times (Figures 6G–J). Conversely, the presence 
of platelets in the context of infection decreased the secretion of 
the anti-inflammatory cytokine IL-10 (Figures  6E,F). Platelets 
FigUre 4 | Brucella abortus infection promotes platelet–monocyte complexes formation in whole blood. Flow cytometry analysis of whole blood untreated  
(a) or treated with B. abortus (B) for 30 min. Monocyte population was stained with a PerCP-labeled anti-CD14 Ab and platelet population was stained with a 
PE-labeled anti-CD61 Ab. Cells were plotted on a CD14 vs. SSC dot plot. Then, the CD14+ cells were plotted on a CD14 vs. CD61 dot plot. Finally, the presence of 
platelet–monocyte complexes (CD14+CD61+) was determined. (c) Quantification of platelet–monocyte complexes within the CD14+ gate. Data are expressed as the 
percentage of monocytes associated with platelets (CD14+CD61+ cells) ± SEM of three independent experiments. (D) CD61 expression in platelet-bearing 
monocytes (CD14+CD61+). Bars represent the arithmetic means ± SEM of three experiments. MFI, mean fluorescence intensity. THP-1:PTL:Ba 1:100:100. 
***P < 0.001 vs. Untreated.
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alone or in presence of B. abortus did not secrete detectable levels 
of the cytokines/chemokines studied (data not shown). These 
results demonstrate that platelets potentiate the secretion of pro-
inflammatory cytokines and chemokines by B. abortus-infected 
monocytes.
Platelets Modulate adhesion and  
co-stimulatory Molecules expression  
on Monocytes in the context of B. abortus 
infection
Under inflammatory conditions, monocytes express a great 
amount of adhesion molecules, among which CD54 (ICAM-1) 
is found (37). In fact, CD54 has been involved in leukocytes 
complexes formation and in the adhesion to the endothelium 
(38). On the other hand, these activated monocytes increase the 
expression of co-stimulatory molecules on their surface, such 
as CD40, facilitating the antigen presentation to cells of adap-
tive immunity (39). Therefore, we next focused on the ability 
of platelets to modulate the expression of CD54 and CD40 on 
monocytes. For this, THP-1 cells were infected with B. abortus 
in presence or absence of platelets for 4  h. Then, the surface 
expression of CD54 and CD40 within the monocyte gate was 
determined by flow cytometry (Figure 7A). B. abortus infection 
slightly but significantly increased the expression of CD54 and 
CD40 (Figures  7B,C). Nevertheless, the presence of platelets 
during B. abortus infection enhanced both CD54 and CD40 
expression on infected monocytes (Figures 7B,C). Overall, these 
results indicate that platelets not only establish complexes with 
B. abortus-infected monocytes, but they also modulate cytokine/
chemokine secretion and co-stimulatory/adhesion molecules 
expression of these monocytes, enhancing their pro-inflamma-
tory capacity.
soluble Factors released by Platelets 
Mediate the Modulation of surface 
Molecules on Monocytes
We next wondered whether the modulation of monocytes by 
platelets in the context of B. abortus infection required physical 
contact between these cell populations; and/or it was mediated 
by soluble factors. To answer this question, THP-1 cells were 
stimulated with supernatants collected from platelets incubated 
in presence or absence of B. abortus. THP-1 cells were also 
stimulated with supernatants collected from bacteria cultured 
alone as control. Then, the surface expression of CD54 within the 
FigUre 5 | Platelets act as carriers of bacteria toward monocytes. (a) Confocal micrographs of THP-1 cells incubated with green fluorescence protein  
(GFP)-Brucella abortus for 2 h and then incubated with platelets for additional 2 h. (B) Platelets were incubated with GFP-B. abortus for 2 h. THP-1 cells were then 
incubated with this suspension for additional 2 h. Monocyte population was stained with an anti-human MHC-I primary Ab and Alexa-633-labeled secondary Ab 
(blue). Platelet population was stained with an anti-human CD61 primary Ab and Alexa-546-labeled secondary Ab (red). Results are representative of three 
independent experiments. THP-1:PTL:Ba 1:100:100. (c) Quantification of THP-1 cell invasion by B. abortus for three experimental conditions: B. abortus-infected 
monocytes in absence of platelets and experimental conditions shown in panels (a,B). Data are expressed as the percentage of monocytes invaded (GFP-positive 
monocytes) ± SEM of three independent experiments. The number of cells counted per experimental group was 200. NS, not significant; ***P < 0.001 vs. 
THP-1 + B. abortus; ###P < 0.001. (D,e) Platelets were incubated with GFP-B. abortus for 2 h. THP-1 cells were then incubated with this suspension for additional 
2 h. Platelets were stained with an anti-human CD61 primary Ab and Alexa-546-labeled secondary Ab (red). 3D reconstruction (D); and Merge Z-stack and 
orthogonal view (e).
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FigUre 6 | Platelets modulate cytokine and chemokine secretion in the context of Brucella abortus infection. THP-1 cells were infected with B. abortus in presence 
or absence of platelets for 4, 8, 12, and 24 h, as indicated. Supernatants were then collected and IL-1β (a,B), TNF-α (c,D), IL-10 (e,F), IL-8 (g,h), and MCP-1  
(i,J) concentration was quantified by ELISA. ***P < 0.001 vs. THP-1. ##P < 0.01; ###P < 0.001 vs. THP-1 + Ba. NS, not significant; ND, not detected. THP-1: 
PTL:Ba 1:100:100.
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FigUre 7 | Platelets modulate adhesion and co-stimulatory molecules expression on monocytes in the context of Brucella abortus infection. THP-1 cells were 
infected with B. abortus in presence or absence of platelets for 4 h. (a) Monocyte population was identified in a FSC vs. SSC dot plot. The surface expression of 
CD54 (B) and CD40 (c) was assessed by flow cytometry within this region. Bars represent the arithmetic means ± SEM of five experiments. MFI, mean 
fluorescence intensity. *P < 0.05; ***P < 0.001 vs. THP-1. ###P < 0.001 vs. THP-1 + Ba. THP-1:PTL:Ba 1:100:100.
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monocyte gate was determined by flow cytometry (Figure 8A). 
Culture supernatant from platelets incubated in presence of 
B. abortus was able to induce the expression of CD54 on mono-
cytes, unlike those of platelets or bacteria alone (Figure  8B). 
This result indicates that there are soluble factors involved in the 
monocyte modulation and that physical contact between platelets 
and monocytes is not indispensable for the modulation of, at 
least, this surface molecule. Among several mediators released 
by platelets upon activation, sCD40L, PF4, PAF, and TXA2 have 
been previously involved in the formation of platelet–monocyte 
complexes in numerous infectious diseases (40–42). Therefore, 
we evaluated the possible role of these factors in the modulation 
of B. abortus-infected monocytes mediated by platelets. For this, 
the expression of CD54 on monocytes was evaluated in neutrali-
zation experiments and/or in experiments using recombinant 
proteins. First, THP-1 cells were incubated with supernatants of 
B. abortus-stimulated platelets in presence or absence of an anti-
sCD40L neutralizing Ab. Neutralization of sCD40L resulted in a 
partial reversion of the CD54 induction mediated by the super-
natant of B. abortus-stimulated platelets (Figure 8C). Confirming 
this result, exposure of THP-1 to recombinant sCD40L slightly 
but significantly induced the surface expression of CD54 on 
monocytes (Figure  8D). Next, THP-1 cells were cultured with 
supernatants of B. abortus-stimulated platelets in presence or 
absence of an anti-PF4 neutralizing Ab. Neutralization of PF4 
was able to partially reverse the induction of CD54 expression 
mediated by the supernatant of B. abortus-stimulated platelets 
(Figure  8E). According with this result, recombinant PF4 was 
able to slightly induce the expression of CD54 on monocytes 
(Figure  8F). To evaluate the role of PAF, THP-1 cells were 
incubated with the recombinant form of this mediator. Exposure 
of THP-1 to recombinant PAF slightly but significantly induced 
the expression of CD54 on monocytes (Figure  8G). Finally, 
regarding the role of TXA2, THP-1 cells were treated with super-
natant collected from B. abortus-stimulated platelets in presence 
or absence of the cyclooxygenase inhibitor aspirin. The inhibition 
of TXA2 formation partially reversed the induction of CD54 
expression mediated by the supernatant of B. abortus-stimulated 
platelets (Figure  8H). Furthermore, the induction of CD54 by 
the combination of sCD40L, PF4, and PAF was more potent 
than the induction obtained by each recombinant protein alone 
(Figure 8I). In addition, supernatant collected from B. abortus-
stimulated platelets in presence of aspirin and then neutralized 
by anti-sCD40L and anti-PF4 was able to completely reverse the 
induction of CD54 expression (Figure 8J). Overall, these results 
demonstrate that there is not a unique soluble factor involved in 
the CD54 modulation of B. abortus-infected monocytes mediated 
by platelets. On the contrary, several factors such as sCD40L, PF4, 
PAF, and TXA2 partially and simultaneously contribute to this 
phenomenon.
Platelets Promote Monocyte invasion by 
B. abortus but improve its control
Finally, we wondered whether the presence of platelets modu-
late the time course of B. abortus infection. For this, THP-1 cells 
were infected with B. abortus in presence or absence of platelets 
at different ratios for 4 h. Then, extracellular bacteria were killed 
by adding antibiotics and the cells were incubated for 24, 48, or 
72 h to study the time course of the infection. Monocytes were 
finally lysed, and the number of viable intracellular bacteria 
was determined by plating the lysates on tryptose-soy agar. As 
shown in Figure 9A, and in agreement with the results shown 
in Figure 2, the presence of platelets significantly increased the 
percentage of B. abortus-infected THP-1 cells. Nevertheless, the 
presence of platelets subsequently improved the control of the 
infection at longer times (Figure 9B). This result demonstrates 
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FigUre 8 | Continued
FigUre 9 | Platelets promote monocyte invasion by Brucella abortus but improve its control. THP-1 cells were infected with B. abortus in presence or absence of 
platelets at different ratios (THP-1:PLT 1:1, 1:10, and 1:100) for 4 h and then incubated with antibiotics for 24, 48, or 72 h. (a) Quantification of monocyte invasion 
by B. abortus after 4 h. Data are expressed as colony-forming units (CFU) per ml. (B) Quantification of monocyte invasion by B. abortus at different times 
post-infection. Data are expressed as relative CFU calculated as: CFU per ml at each time point (24, 48, or 72 h) relative to the CFU per ml measured for the same 
condition at 4 h.
FigUre 8 | Soluble factors released by platelets mediate the modulation of surface molecules on monocytes. THP-1 cells were stimulated with supernatants 
collected from platelets incubated in presence or absence of Brucella abortus and assessed by flow cytometry. Monocyte population was identified in a FSC  
vs. SSC dot plot (a) and the CD54 surface expression was quantified within this region (B). Supernatants from bacteria cultured alone were used as control. Bars 
represent the arithmetic means ± SEM of three experiments. MFI, mean fluorescence intensity. THP-1 cells were incubated with supernatants of B. abortus-
stimulated platelets in presence or absence of neutralizing Ab to soluble CD40L (sCD40L) (c) or platelet factor 4 (PF4) (e). THP-1 cells were stimulated with sCD40L 
(D), PF4 (F), or platelet-activating factor (PAF) (g) in their recombinant forms. (h) THP-1 cells were treated with supernatant collected from B. abortus-stimulated 
platelets in presence or absence of aspirin. (i) THP-1 cells were stimulated with a combination of sCD40L, PF4, and PAF. (J) THP-1 cells were treated with 
supernatant obtained from B. abortus-stimulated platelets in presence or absence of aspirin plus anti-sCD40L and anti-PF4 neutralizing antibodies. In all cases, 
CD54 surface expression was assessed by flow cytometry after the different treatments. Bars represent the times of CD54 induction ± SEM of three experiments. 
**P < 0.01; ***P < 0.001 vs. untreated. ###P < 0.001. NS, not significant. THP-1:PTL:Ba 1:100:100.
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that despite promoting the invasion of monocytes, platelets 
improve the control of B. abortus within the infected monocytes.
DiscUssiOn
This is the first study elucidating the role of platelets in the 
immune response against B. abortus. Particularly, we demon-
strated that platelets directly interact with B. abortus and behave 
as carriers of these bacteria promoting the invasion of monocytes/
macrophages. As a consequence of this activity, platelets establish 
complexes with infected monocytes. This platelet–monocyte 
interaction, together with the release of soluble factors, triggers 
an increase in the pro-inflammatory response of the infected 
monocytes.
Our interaction experiments between B. abortus and platelets 
demonstrated that both populations are intimately associated. 
Moreover, this interaction is capable of triggering platelet activa-
tion. In line with this result, it has been described that platelet 
activation can be triggered by bacteria binding to TLRs, receptors 
for the complement, FcγRII, and/or several adhesion molecules 
present on platelets surface, as demonstrated for Streptococcus 
sanguinis, Staphylococcus epidermidis, and Chlamydia pneumo-
niae (36).
Interestingly, our results indicated that bacteria not only bind to 
platelets but also invade them. These results are in agreement with 
several studies which demonstrate the ability of activated platelets 
to internalize bacteria such as Staphylococcus aureus, Escherichia 
coli, and Porphyromonas gingivalis (43–46). These studies suggest 
that internalization might have consequences in bacterial fate. 
It would either protect the bacteria from the immune system or 
promote the lysis of the bacteria within the platelet cytoplasm 
(43–46). Although the presence of phagolysosomes in platelets 
has not been demonstrated yet, it has been observed that plate-
lets can actively phagocyte S. aureus and secrete antimicrobial 
molecules such as β-defensin. In turn, this leads to the formation 
of platelet–neutrophil complexes and NETs which help in the 
bacteria immobilization and elimination (24). The fact that an 
intracellular pathogen such as B. abortus invades a short half-
life cell population might seem curious, taking into account the 
chronic predisposition of this infection. However, it is possible 
that the internalization of the bacteria by platelets functions as a 
mechanism to evade the immune system. Thus, B. abortus would 
remain hidden inside platelets until it reaches its main replicative 
niche, the monocyte/macrophage. In line with this, our result 
showed that platelets behave as carriers of B. abortus toward the 
monocytes and thus they might help with the transportation of 
the bacteria through the bloodstream to its replicative niche. 
Nevertheless, whether the bacteria may also be destroyed inside 
platelets remains unknown and it is an interesting issue which 
merits further investigation.
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The central role of monocytes/macrophages has been exten-
sively described in Brucella infection. During the initial stages of 
infection, macrophages show a significant microbicidal capacity, 
contributing to the control of the infection. However, they have 
also been proved to be the main niche for B. abortus replication, 
allowing the persistence of the bacteria. Therefore, once the 
interaction between B. abortus and platelets was corroborated, we 
focused on investigating whether platelets were able to modulate 
the infective capacity and/or immunological features of these 
cells. Our results demonstrated that the presence of platelets pro-
mote B. abortus-mediated invasion of monocytes/macrophages. 
In addition, our results showed that the co-incubation of the three 
cell populations leads to the formation of platelet–monocyte 
complexes. Moreover, the disposition of platelets in these com-
plexes was particular, as they completely surround the infected 
monocytes creating rosettes as has been described in the literature 
(47). In line with our results, platelets have been widely implicated 
in the formation of complexes with neutrophils and monocytes 
(12–14). It has been described that the interaction between plate-
lets and monocytes is predominantly through the interaction of 
P-selectin with the ligand of P-selectin (PSGL-1) expressed on the 
monocyte surface (48, 49). It has been proven that the interaction 
of activated platelets with monocytes induce the maturation of 
a pro-inflammatory subtype of monocytes (47, 50). In addition, 
these complexes are usually increased in the circulation of patients 
with chronic inflammation-associated diseases, such as HIV (41, 
42). Taking together, these observations suggest that the presence 
of platelet–monocyte complexes in the bloodstream may be used 
as an indicator of an inflammatory state.
Based on our confocal microscopy studies, we were able to 
demonstrate that platelets form complexes with B. abortus-
infected monocytes. Furthermore, the interaction between 
platelets and bacteria triggers platelet activation, promotes the 
transportation of bacteria toward monocytes and, as a conse-
quence, the formation of platelet–monocyte complexes. In line 
with these results, other in vitro studies have shown that platelet 
activation, rather than monocyte activation, is responsible for the 
formation of these mixed complexes (51).
Regarding the modulation of functional aspects of monocytes/
macrophages, our results demonstrated that the presence of plate-
lets in the context of B. abortus infection increases the secretion 
of IL-1β, TNF-α, IL-8, and MCP-1, while it inhibits the secretion 
of IL-10. Supporting these results, it has been described that the 
interaction between monocytes and platelets for prolonged time 
induces an increase in the secretion of IL-8, MCP-1, and IL-1β 
(47, 52) together with other soluble factors such as tissue factor 
(47, 53–55). In particular, it has been proven that in the context 
of an S. aureus-mediated infection, activated platelets release 
β-defensin which slow down the bacterial growth rate, induces 
the formation of NETs and the expression of IL-8 and MCP-1 by 
macrophages (24).
With respect to the modulation of surface molecules, our 
results demonstrated that the presence of platelets increases the 
expression of the intercellular adhesion molecule CD54 (ICAM-
1). These results, together with the increase in MCP-1 secretion, 
suggest the presence of a positive feedback loop, which promote 
the recruitment and adhesion of circulating monocytes to the 
activated endothelium in infected foci.
Although both P-selectin and GPIIb/IIIa are usually involved 
in the intracellular signaling pathways activated in the platelet–
leukocyte crosstalk, Li et  al. have suggested that this crosstalk 
would be mainly dependent on soluble mediators, and not on 
cell–cell interactions (51). In line with this suggestion, our results 
demonstrated that platelets are able to modulate B. abortus-
infected monocytes functionality, at least in part, by secretion 
of soluble factors. Particularly, we confirmed that sCD40L, PF4, 
PAF, and thromboxane A2 released from platelets orchestrate the 
CD54 modulation on monocytes. According to these results, it 
has been proposed that platelet-derived sCD40L modulates the 
activation state of monocytes, by interacting with CD40 in the 
monocyte surface. In particular, this interaction has been shown 
to stimulate the secretion of cytokines, such as IL-8, and the 
monocytes tumoricidal activity, without additional stimulus (39). 
Supporting the importance of the sCD40L–CD40 interaction, 
our results demonstrated that platelets were also able to increase 
the expression of CD40 on the surface of monocytes.
It has been recently demonstrated that PF4 and thromboxane 
A2 released by platelets are soluble mediators involved in the 
formation of NETs (56). Moreover, PF4 prevents the spontaneous 
apoptosis of human monocytes and induces the differentiation 
of monocytes into a specific subtype of macrophages (57). In 
addition, PF4 is a potent activator of phagocytosis and promotes 
the respiratory burst in human monocytes as well as human and 
murine macrophages (58).
Regarding PAF, it has been recently demonstrated that PAF 
receptor (PAFR) activation promotes phagocytosis, and it is 
involved in the uptake of B. abortus by monocytes (59). However, 
in this study, the authors only used recombinant PAF to stimulate 
monocytes without taking into account the role of platelets dur-
ing infection. In light of our experiments, we might speculate that 
PAF released by platelets, through their binding to the PAFR, 
would lead to the greater invasion of monocytes by B. abortus 
that we observed in the presence of platelets.
The role of platelets in the pathogenesis of diverse infectious 
diseases is a topic worth of discussion. Recently, it has been 
described that platelets contribute to Streptococcus pyogenes dis-
semination (12). In addition, mice infected with these bacteria 
exhibited thrombocytopenia, platelet activation, and formation 
of platelet–neutrophil complexes. In this context, platelet-
depleted mice showed reduced bacterial dissemination rate and 
decreased levels of systemic IL-6 (12). By contrast, other studies 
reveal that platelet-depleted mice rapidly succumb to LPS- (60) or 
S. aureus-induced sepsis (14). Likewise, it has been demonstrated 
in  vivo that the interaction between platelets and Kupffer cells 
in liver contribute to blood-borne pathogens elimination such as 
Bacillus cereus and S. aureus (61). Thus, platelets can play either 
a beneficial or detrimental role during the infection elicited by 
different pathogens. But what is the role of platelets during the 
development of human brucellosis? Our result demonstrates 
that platelets promote the invasion of monocytes by B. abortus. 
Moreover, platelets potentiate the secretion of monocyte-
derived pro-inflammatory cytokines and chemokines, causing a 
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pro-inflammatory environment. This microenvironment, along 
with direct interaction within platelet–monocyte complexes, may 
induce monocytes differentiation into a potent pro-inflammatory 
profile with an enhanced microbicidal capacity. Altogether, these 
results suggest a protective role of platelets in brucellosis in 
which platelets diminish the bacterial load in the bloodstream 
by promoting the uptake and control of B. abortus by mono-
cytes. Nevertheless, bacteria are able to evade the early defense 
mechanisms establishing a chronic infection. In fact, it has been 
described that patients with chronic brucellosis usually presents 
thrombocytopenia, which is associated with greater severity 
of the disease (4, 6). Many causes could explain the decreased 
platelet count observed in patients with brucellosis. Our results 
suggest that the formation of platelet–monocyte complexes could 
contribute, at least in part, to decreasing the level of platelets in 
the bloodstream. In line with this, it was demonstrated that the 
activation of platelets and the formation of platelet–monocyte 
aggregates contribute to the decreased platelet count observed 
in macaques during the infection with acute simian immuno-
deficiency virus (62). The causes that determine the brucellosis-
associated thrombocytopenia and the in  vivo role of platelets 
during the development of this disease are important aspects that 
remain to be explored.
Given the potential protective role of platelets, we postulate 
that the reduction of platelets in the bloodstream, due to the 
formation of platelet–monocyte complexes, could contribute to 
the development of brucellosis and the persistence of infection. 
Overall, our results highlight the relevance of platelets as con-
tributors to host defense against Brucella.
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